Oxford, United Kingdom · Founded 2013 · Privately Held (backing)
Operator of a therapeutics platform intended to develop an anti-cancer therapy to improve the delivery of agents to tumors by disrupting their structure. OxSonics Therapeutics is based in Oxford, United Kingdom and was founded in 2013. Its last reported valuation was $34.6 million in Jul 2020. It has raised $30.2 million.
Last reported valuation
$34.6M
Oct 2026
Priced at
—
Total raised
$30.2M
Last round
—
Team — not yet on record
No current team members for OxSonics Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of OxSonics Therapeutics with a free account
·Watch OxSonics Therapeutics: the Monday email on marks, rounds and moves
